Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank71
5Y CAGR-5.1%
Year-over-Year Change
Year-over-year revenue growth rate
5Y CAGR
-5.1%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 64.15% |
| 2024 | 53.38% |
| 2023 | -2.79% |
| 2022 | -19.43% |
| 2021 | 37.39% |
| 2020 | 83.21% |
| 2019 | 33.20% |
| 2018 | 892.62% |
| 2017 | -78.00% |
| 2016 | -29.46% |